Advertisement

Topics

BioPortfolio Blog about Biotechnology, Pharmaceutical and Healthcare

15:06 EDT 21st May 2018 | BioPortfolio

Updates and info from the contributors bringing you BioPortfolio.com.

Showing News Articles 1–5 of 37,000+

Monday 21st May 2018

Will 'Public Shaming' Sink Celgene?

The FDA posted a list of companies who have been targets of complaints by generic drug makers. CELG topped the list.

Sunday 20th May 2018

Critical Analysis: LabCorp

LabCorp and CareDx are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations. LabCorp presently has a consensus price target of $190.47, suggesting a potential upside of 8.09%.

XuanZhu Pharma Co Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19032018] Prices from USD $250

SummaryXuanZhu Pharma Co Ltd XuanZhu, a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company's products include antiinfective drugs apapenem and benapenem; antiacid drug anaprazole sodium, antidiabetic drug imigliptin hydrochloride and antihypertensive drug tylerdipine hydrochloride. Its technology platfor...

Lannett Co Inc (LCI) Given Average Recommendation of "Hold" by Analysts

Shares of Lannett Co Inc have been given a consensus rating of "Hold" by the eight analysts that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company.

Agenus Inc (AGEN) Stake Decreased by Chicago Equity Partners LLC

Chicago Equity Partners LLC lessened its stake in shares of Agenus Inc by 38.6% in the 1st quarter, Holdings Channel reports. The institutional investor owned 214,675 shares of the biotechnology company's stock after selling 134,950 shares during the quarter.


Advertisement
Quick Search
Advertisement
Advertisement